(Q81258373)

English

Stabilization of rapidly worsening multiple sclerosis for 36 months in patients treated with interferon beta plus cyclophosphamide followed by interferon beta

scientific article published on 01 December 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15645351%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Stabilization of rapidly worsening multiple sclerosis for 36 months in patients treated with interferon beta plus cyclophosphamide followed by interferon beta (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15645351%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

multiple sclerosis

1 reference

based on heuristic

inferred from title

Alessandra Nicoletti

6

object named as

Alessandra Nicoletti

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15645351%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

author name string

Francesco Patti

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15645351%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Ester Reggio

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15645351%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Filippo Palermo

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15645351%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Teresa Fiorilla

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15645351%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Guido Politi

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15645351%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Arturo Reggio

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15645351%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

publication date

1 December 2004

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15645351%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Journal of Neurology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15645351%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

251

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15645351%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15645351%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1502-1506

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15645351%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

https://scigraph.springernature.com/pub.10.1007/s00415-004-0581-2

0 references

Effect of monthly intravenous cyclophosphamide in rapidly deteriorating multiple sclerosis patients resistant to conventional therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/15645351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of cyclophosphamide pretreatment on autoimmune encephalomyelitis in rats.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15645351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination of cyclophosphamide and interferon-beta halts progression in patients with rapidly transitional multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15645351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neutralising antibodies to interferon beta during the treatment of multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15645351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15645351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteria

1 reference

https://pubmed.ncbi.nlm.nih.gov/15645351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions. A quantitative study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15645351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunological aspects of demyelinating diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/15645351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclophosphamide: Effect on Experimental Allergic Encephalomyelitis in Lewis Rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/15645351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclophosphamide in chronic progressive multiple sclerosis. Maintenance vs nonmaintenance therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/15645351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunologic Mechanisms and Therapy in Multiple Sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15645351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of intensive immunosuppression on the course of chronic progressive multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15645351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Experimental allergic encephalomyelitis in the Lewis rat. A model of predictable relapse by cyclophosphamide.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15645351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunosuppression with high-dose i.v. cyclophosphamide and ACTH in progressive multiple sclerosis: cumulative 6-year experience in 164 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/15645351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 reference

https://pubmed.ncbi.nlm.nih.gov/15645351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intensive immunosuppression with cyclophosphamide in multiple sclerosis. Follow up of 110 patients for 2-6 years

1 reference

https://pubmed.ncbi.nlm.nih.gov/15645351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Axonal transection in the lesions of multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15645351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of open label pulse cyclophosphamide therapy on MRI measures of disease activity in five patients with refractory relapsing-remitting multiple sclerosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15645351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic-relapsing experimental autoimmune encephalomyelitis (CR-EAE): treatment and induction of tolerance, with high dose cyclophosphamide followed by syngeneic bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/15645351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of multiple sclerosis with cyclophosphamide: critical review of clinical and immunologic effects

1 reference

https://pubmed.ncbi.nlm.nih.gov/15645351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q81258373&oldid=1751953811"